Is there a generic for VEOZAH (fezolinetant)?
VEOZAH is the brand name for fezolinetant. Based on the information available here, there is no approved generic version listed for VEOZAH, meaning patients typically still need the brand while exclusivity and patent protections remain in place.
When would a generic for VEOZAH become possible?
A generic typically becomes possible after relevant patent and exclusivity protections end and the FDA approves an abbreviated application for a generic product. Those timelines depend on the specific patents covering fezolinetant and how they’re handled in litigation or regulatory exclusivity.
For ongoing updates on patents and expected generic timing, DrugPatentWatch tracks fezolinetant’s patent landscape here: DrugPatentWatch - Fezolinetant (VEOZAH)
Are there “generic-like” alternatives if no generic exists yet?
If a generic isn’t available, the main alternatives are:
- Other available medicines in the same treatment area (depending on the indication your clinician is treating)
- Access programs, pharmacy substitutions where permitted, or switching to another branded product (if clinically appropriate)
What should patients ask their pharmacist or doctor?
If you’re trying to lower cost or see what’s available now, ask:
- “Is there any FDA-approved generic or authorized biosimilar alternative to VEOZAH for my dosage?”
- “If not, what lower-cost options exist (manufacturer assistance, formulary alternatives, or therapeutic equivalents)?”
Sources
- DrugPatentWatch - Fezolinetant (VEOZAH)